Verona Pharma (VRNA) Competitors $74.73 +2.15 (+2.96%) Closing price 05/20/2025 04:00 PM EasternExtended Trading$74.66 -0.08 (-0.10%) As of 07:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VRNA vs. TEVA, SMMT, ITCI, GMAB, RDY, VTRS, MRNA, QGEN, ASND, and ROIVShould you be buying Verona Pharma stock or one of its competitors? The main competitors of Verona Pharma include Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), Moderna (MRNA), Qiagen (QGEN), Ascendis Pharma A/S (ASND), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry. Verona Pharma vs. Teva Pharmaceutical Industries Summit Therapeutics Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories Viatris Moderna Qiagen Ascendis Pharma A/S Roivant Sciences Verona Pharma (NASDAQ:VRNA) and Teva Pharmaceutical Industries (NYSE:TEVA) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, community ranking, analyst recommendations, media sentiment, profitability, earnings, dividends and risk. Do analysts prefer VRNA or TEVA? Verona Pharma presently has a consensus target price of $81.50, indicating a potential upside of 9.06%. Teva Pharmaceutical Industries has a consensus target price of $24.43, indicating a potential upside of 45.84%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher probable upside, analysts clearly believe Teva Pharmaceutical Industries is more favorable than Verona Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Verona Pharma 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.11Teva Pharmaceutical Industries 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Do institutionals & insiders hold more shares of VRNA or TEVA? 85.9% of Verona Pharma shares are owned by institutional investors. Comparatively, 54.0% of Teva Pharmaceutical Industries shares are owned by institutional investors. 4.8% of Verona Pharma shares are owned by insiders. Comparatively, 0.5% of Teva Pharmaceutical Industries shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher valuation and earnings, VRNA or TEVA? Verona Pharma has higher earnings, but lower revenue than Teva Pharmaceutical Industries. Verona Pharma is trading at a lower price-to-earnings ratio than Teva Pharmaceutical Industries, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVerona Pharma$118.54M51.12-$54.37M-$2.00-37.37Teva Pharmaceutical Industries$16.62B1.14-$1.64B-$1.15-14.57 Which has more risk & volatility, VRNA or TEVA? Verona Pharma has a beta of 0.2, indicating that its stock price is 80% less volatile than the S&P 500. Comparatively, Teva Pharmaceutical Industries has a beta of 0.62, indicating that its stock price is 38% less volatile than the S&P 500. Does the media favor VRNA or TEVA? In the previous week, Teva Pharmaceutical Industries had 26 more articles in the media than Verona Pharma. MarketBeat recorded 36 mentions for Teva Pharmaceutical Industries and 10 mentions for Verona Pharma. Verona Pharma's average media sentiment score of 1.50 beat Teva Pharmaceutical Industries' score of 1.11 indicating that Verona Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Verona Pharma 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Teva Pharmaceutical Industries 22 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community favor VRNA or TEVA? Teva Pharmaceutical Industries received 1002 more outperform votes than Verona Pharma when rated by MarketBeat users. However, 80.96% of users gave Verona Pharma an outperform vote while only 67.88% of users gave Teva Pharmaceutical Industries an outperform vote. CompanyUnderperformOutperformVerona PharmaOutperform Votes33680.96% Underperform Votes7919.04%Teva Pharmaceutical IndustriesOutperform Votes133867.88% Underperform Votes63332.12% Is VRNA or TEVA more profitable? Verona Pharma has a net margin of 0.00% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Verona Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Verona PharmaN/A -79.54% -43.49% Teva Pharmaceutical Industries -9.91%42.46%6.65% SummaryTeva Pharmaceutical Industries beats Verona Pharma on 10 of the 18 factors compared between the two stocks. Get Verona Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRNA vs. The Competition Export to ExcelMetricVerona PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.06B$6.54B$5.42B$8.48BDividend YieldN/A2.66%5.22%4.11%P/E Ratio-38.929.1426.8020.05Price / Sales51.12255.60393.93116.47Price / CashN/A65.8538.2534.62Price / Book24.116.546.864.61Net Income-$54.37M$143.51M$3.22B$248.19M7 Day Performance11.14%5.60%6.81%2.97%1 Month Performance24.40%10.06%13.72%16.58%1 Year Performance497.84%-0.86%18.24%8.16% Verona Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRNAVerona Pharma1.885 of 5 stars$74.73+3.0%$81.50+9.1%+484.7%$6.06B$118.54M-38.9230Positive NewsTEVATeva Pharmaceutical Industries3.3596 of 5 stars$17.92+5.8%$24.43+36.4%-0.4%$20.31B$16.62B-12.3636,800SMMTSummit Therapeutics3.2121 of 5 stars$25.26+5.4%$37.40+48.1%+437.2%$18.76B$700,000.00-90.21110Positive NewsITCIIntra-Cellular Therapies0.8725 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560GMABGenmab A/S3.3376 of 5 stars$19.93+2.9%$39.17+96.5%-31.5%$12.78B$21.64B11.451,660News CoveragePositive NewsHigh Trading VolumeRDYDr. Reddy's Laboratories2.3617 of 5 stars$13.93+3.9%$17.00+22.1%+5.3%$11.62B$311.31B22.1724,800Positive NewsGap UpVTRSViatris2.1288 of 5 stars$8.96+2.2%$10.50+17.2%-19.8%$10.63B$14.33B-12.1137,000Trending NewsGap UpMRNAModerna4.5272 of 5 stars$25.70+6.0%$53.95+109.9%-80.2%$9.94B$3.14B-2.773,900Trending NewsQGENQiagen4.0535 of 5 stars$42.92+2.5%$48.42+12.8%-3.4%$9.54B$1.98B119.526,030Positive NewsASNDAscendis Pharma A/S3.5483 of 5 stars$154.43+2.1%$216.07+39.9%+33.5%$9.42B$368.70M-21.75640Positive NewsROIVRoivant Sciences2.0132 of 5 stars$10.99+3.3%$17.50+59.2%-2.9%$7.84B$122.59M-73.26860Positive News Related Companies and Tools Related Companies TEVA Alternatives SMMT Alternatives ITCI Alternatives GMAB Alternatives RDY Alternatives VTRS Alternatives MRNA Alternatives QGEN Alternatives ASND Alternatives ROIV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRNA) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VRNA Stock Free VRNA Stock Alerts